cyproterone acetate has been researched along with acid phosphatase in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kastelan, M; Kraljić, I; Tarle, M | 1 |
| Radoś, N; Tarle, M | 1 |
| Schulze, H; Senge, T | 1 |
| Bolt, J; Mulder, E; Schuurmans, AL; Veldscholte, J | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F; Serio, M | 1 |
| Cunningham, GR; Kong, AY; Shao, TC | 1 |
| Arvis, G; Tobelem, G | 1 |
| Bruchovsky, N; Coppin, CM; Goldenberg, SL; Rennie, PS | 1 |
| Neumann, F; Schenck, B; Senge, T; Tunn, U | 1 |
| Akakura, K; Bruchovsky, N; Goldenberg, SL; Rennie, PS | 1 |
| de Pauw, M; de Voogt, HJ; Klijn, JG; Schröder, FH; Studer, U; Sylvester, R | 1 |
| Al-Baghly, S; Alnaqeeb, M; Sabry, I | 1 |
3 trial(s) available for cyproterone acetate and acid phosphatase
| Article | Year |
|---|---|
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1990 |
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pituitary Gland; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Survival Rate; Testosterone | 1993 |
Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis o
Topics: Acid Phosphatase; Administration, Intranasal; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Cause of Death; Cyproterone Acetate; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Subcutaneous; Male; Middle Aged; Orchiectomy; Pain Measurement; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Survival Rate; Treatment Outcome | 1998 |
9 other study(ies) available for cyproterone acetate and acid phosphatase
| Article | Year |
|---|---|
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo.
Topics: Acid Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Cyproterone Acetate; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diethylstilbestrol; Estradiol; Estramustine; Flutamide; Hormones; Humans; Hydrocortisone; Killer Cells, Natural; Male; Orchiectomy; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1992 |
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Topics: Acid Phosphatase; Antigens, Neoplasm; Antineoplastic Agents; APUD Cells; Biomarkers, Tumor; Carcinoembryonic Antigen; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Flutamide; Humans; Male; Orchiectomy; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Topics: Acid Phosphatase; Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; ErbB Receptors; Estradiol; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 1990 |
Acid phosphatase activity: a marker of androgen action in prostate explant cultures.
Topics: Acid Phosphatase; Animals; Cells, Cultured; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Flutamide; Hydrocortisone; Male; Prostate; Rats; Rats, Inbred Strains | 1987 |
[Cyproterone acetate. Its value in the treatment of prostatic cancer. Apropos of 45 cases].
Topics: Acid Phosphatase; Androgen Antagonists; Bone Neoplasms; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Radionuclide Imaging; Retrospective Studies | 1988 |
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Evaluation; Drug Synergism; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Testosterone | 1988 |
Effects of cyproterone acetate on experimentally induced canine prostatic hyperplasia. A morphological and histochemical study.
Topics: Acid Phosphatase; Aminopeptidases; Androstanols; Animals; Castration; Cyproterone; Cyproterone Acetate; Disease Models, Animal; Dogs; Estradiol; Male; Prostatic Hyperplasia; Zinc | 1980 |
beta-glucuronidase activity is elevated in the rat harderian gland after bromocriptine but decreased after cyproterone acetate treatment or castration. Postcastrational effects on the ultrastructure of the gland.
Topics: Acid Phosphatase; Androgen Antagonists; Animals; Bromocriptine; Cyproterone Acetate; Epithelial Cells; Glucuronidase; Harderian Gland; Hormone Antagonists; Male; Microscopy, Electron; Orchiectomy; Prolactin; Rats | 2000 |